Neridronate sodium salt is a bisphosphonate compound primarily used in the treatment of bone disorders, particularly for conditions such as osteoporosis and Paget's disease. It functions by inhibiting osteoclast-mediated bone resorption, thereby helping to maintain or increase bone density. The compound is characterized by its ability to bind to hydroxyapatite in bone tissue, which enhances its therapeutic efficacy. Neridronate sodium salt is typically administered intravenously and has a favorable pharmacokinetic profile, allowing for effective dosing regimens. It is known for its relatively low toxicity and side effects compared to other bisphosphonates. The chemical structure includes a phosphorus atom bonded to carbon and nitrogen, contributing to its stability and biological activity. Additionally, neridronate sodium salt is soluble in water, which facilitates its use in clinical settings. Overall, it represents a significant advancement in the management of metabolic bone diseases, promoting skeletal health and reducing the risk of fractures.

NERIDRONATE, SODIUM SALT

80729-79-9: Neridronate sodium salt is a bisphosphonate compound primarily used in the treatment of bone disorders, particularly for conditions such as osteoporosis and Paget's disease. It functions by inhibiting osteoclast-mediated bone resorption, thereby helping to maintain or increase bone density. The compound is characterized by its ability to bind to hydroxyapatite in bone tissue, which enhances its therapeutic efficacy. Neridronate sodium salt is typically administered intravenously and has a favorable pharmacokinetic profile, allowing for effective dosing regimens. It is known for its relatively low toxicity and side effects compared to other bisphosphonates. The chemical structure includes a phosphorus atom bonded to carbon and nitrogen, contributing to its stability and biological activity. Additionally, neridronate sodium salt is soluble in water, which facilitates its use in clinical settings. Overall, it represents a significant advancement in the management of metabolic bone diseases, promoting skeletal health and reducing the risk of fractures.

CAS 80729-79-9

NERIDRONATE, SODIUM SALT

Neridronate Sodium Salt

Ref: TR-N390025